Literature DB >> 6146864

Decrease of vasoactive intestinal polypeptide (VIP) in the penises from impotent men.

J Gu, J M Polak, M Lazarides, R Morgan, J P Pryor, P J Marangos, M A Blank, S R Bloom.   

Abstract

Vasoactive intestinal polypeptide (VIP)-containing nerves were depleted in the penises of 28 impotent men. The extent of the decrease in VIP-containing nerves broadly reflected the severity of erectile dysfunction. VIP-immunoreactive nerves were most depleted in those men with complete erectile impotence, irrespective of the aetiology of the dysfunction, whereas in those men in whom some erectile function persisted, loss of VIP-immunoreactive nerves was more variable and less complete. Conventional histology demonstrated only mild changes (muscle atrophy and occasional thickening of blood vessel walls). VIP levels, measured by radioimmunoassay of tissue extracts, were depleted by more than 80% in penises from impotent diabetics (43.4 +/- 9.9 pmol/g wet weight [mean +/- SEM]), when compared with 6 controls (189.9 +/- 45.9 pmol/g). These findings not only support the contention that VIP may be the principal neurotransmitter involved in penile erection, but also suggest that depletion of this powerful vasodilatory peptide may play a key role in the development of penile impotence.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6146864     DOI: 10.1016/s0140-6736(84)92687-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  11 in total

Review 1.  Drugs for the treatment of impotence.

Authors:  L Garcia-Reboll; J P Mulhall; I Goldstein
Journal:  Drugs Aging       Date:  1997-08       Impact factor: 3.923

Review 2.  Regulation of tone in penile cavernous smooth muscle. Established concepts and new findings.

Authors:  K E Andersson; F Holmquist
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

Review 3.  Some aspects of neuroendocrine pathology.

Authors:  J M Polak; S R Bloom
Journal:  J Clin Pathol       Date:  1987-09       Impact factor: 3.411

Review 4.  Calcitonin gene-related peptide. Potential role in vascular disorders.

Authors:  A Shulkes
Journal:  Drugs Aging       Date:  1993 May-Jun       Impact factor: 3.923

5.  Depletion of cutaneous nerves and neuropeptides in diabetes mellitus: an immunocytochemical study.

Authors:  D M Levy; S S Karanth; D R Springall; J M Polak
Journal:  Diabetologia       Date:  1989-07       Impact factor: 10.122

6.  Elevated levels of vasoactive intestinal peptide in the eye and urinary bladder of diabetic and prediabetic Chinese hamsters.

Authors:  A R Diani; T Peterson; G A Sawada; B M Wyse; M C Blanks; G C Gerritsen; G Terenghi; I M Varndell; J M Polak; M A Blank
Journal:  Diabetologia       Date:  1985-05       Impact factor: 10.122

7.  A fatty neuropeptide. Potential drug for noninvasive impotence treatment in a rat model.

Authors:  I Gozes; M Fridkin
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

8.  Evidence against vasoactive intestinal polypeptide as the relaxant neurotransmitter in human cavernosal smooth muscle.

Authors:  R S Pickard; P H Powell; M A Zar
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

9.  Changes in the somatostatin, substance P and vasoactive intestinal polypeptide content of the gastrointestinal tract following streptozotocin-induced diabetes in the rat.

Authors:  M Ballmann; J M Conlon
Journal:  Diabetologia       Date:  1985-06       Impact factor: 10.122

10.  Experimental diabetes mellitus inhibits prostacyclin synthesis by the rat penis: pathological implications.

Authors:  J Y Jeremy; C S Thompson; D P Mikhailidis; P Dandona
Journal:  Diabetologia       Date:  1985-06       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.